roche holding ag eu agency supports wider use for drugs switzerland based drug maker roche holding ag received backing for wider use of three cancer drugs in the european union and said partner company chugai pharmaceutical co is to launch lung cancer drug tarceva in japan the european medicines agency recommended the european commission approve avastin to treat metastatic colorectal cancer with fluropyrimidine based chemotherapy it also backed wider use of xeloda and mabthera 
